NCT04823923View on ClinicalTrials.gov

Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
Kidney Neoplasm
Interventions
OTHER

blood sampling for ITK dosage

Blood sample for ITK dosage at visit 1 (1 month +/- 1 week after the start of treatment) and at visit 2 (3 months +/- 1 month after the start of treatment)

Trial Locations (5)

13005

RECRUITING

APHM Hôpital LA TIMONE, Marseille

30029

RECRUITING

CHU de Nîmes, Institut de Cancérologie du Gard, Nîmes

31059

RECRUITING

Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse

34295

RECRUITING

CHU Montpellier - Hôpital St Eloi, Montpellier

34298

RECRUITING

ICM Val d'Aurelle, Montpellier

All Listed Sponsors
collaborator

Ligue contre le cancer, France

OTHER

lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER